Shanghai Pharmaceutical Distribution Co., Sustainability Profile
Shanghai Pharmaceutical Distribution Co., Ltd., commonly referred to as Shanghai Pharma, is a leading player in the pharmaceutical distribution industry, headquartered in Shanghai, China. Established in 1994, the company has expanded its operations across major regions in China, solidifying its presence in the healthcare supply chain. Specialising in the distribution of pharmaceuticals, medical devices, and healthcare products, Shanghai Pharma is renowned for its efficient logistics and comprehensive service offerings. The company prides itself on its commitment to quality and innovation, ensuring that healthcare providers have access to essential medications and supplies. With a strong market position, Shanghai Pharmaceutical Distribution Co. has achieved significant milestones, including strategic partnerships and a robust distribution network. Its dedication to enhancing healthcare accessibility makes it a pivotal entity in the pharmaceutical landscape of China.
DitchCarbon Score
How does Shanghai Pharmaceutical Distribution Co.,'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shanghai Pharmaceutical Distribution Co.,'s score of 2 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shanghai Pharmaceutical Distribution Co.,'s reported carbon emissions
Shanghai Pharmaceutical Distribution Co., headquartered in CN, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd, which may influence its climate commitments and reporting practices. While there are no documented reduction targets or climate pledges from Shanghai Pharmaceutical Distribution Co., it is important to note that emissions data may be inherited from its parent company. The parent organization, Shanghai Pharmaceuticals Holding Co., Ltd, is likely to have its own climate initiatives and targets, which could impact the subsidiary's approach to carbon emissions and sustainability. As of now, without specific emissions data or reduction initiatives, it is unclear how Shanghai Pharmaceutical Distribution Co. is addressing climate change. The company may benefit from aligning with industry standards and best practices in emissions reduction, particularly in the pharmaceutical distribution sector, which is increasingly focused on sustainability and carbon footprint minimisation.
How Carbon Intensive is Shanghai Pharmaceutical Distribution Co.,'s Industry?
How Carbon Intensive is Shanghai Pharmaceutical Distribution Co.,'s Location?
Shanghai Pharmaceutical Distribution Co.,'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Shanghai Pharmaceutical Distribution Co., has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
